Mortality and Morbidity in Acute Heart Failure with Cerebrovascular Accident (Stroke/Transient Ischemic Attack) Stratified by Ejection Fraction
Open Access
- 1 January 2024
- journal article
- research article
- Published by Medknow in Annals of Clinical Cardiology
- Vol. 6 (1) , 23-35
Abstract
Background: Heart failure (HF) is a prevalent condition in our society, frequently accompanied by various interacting comorbidities. Among these, brain-related comorbidities such as stroke and transient ischemic attack (TIA) play a crucial role in exacerbating the severity of HF. The relationship between cerebrovascular accidents (CVAs) and HF across different left ventricular ejection fraction (LVEF) levels is not well understood. Objectives: This study aims to assess the impact of CVA including stroke and TIA on mortality and morbidity in patients with acute heart failure (AHF) stratified by LVEF. Methods: We conducted an analysis of consecutive patients admitted to 47 hospitals in seven Middle Eastern countries (Saudi Arabia, Oman, Yemen, Kuwait, United Arab Emirates, Qatar, and Bahrain) with AHF from February to November 2012 with AHF who were enrolled in a multinational registry of patients with HF. The study population consisted of patients with CVA and AHF, categorized into three groups based on EF: HF patients with preserved EF (HFpEF) (250%), HF patients with reduced EF (HFrEF) (n = 31). Patients in different ranges of LVEF experienced comparable rates of hospitalization and mortality at both the 3-month and 12-month intervals. Left atrial enlargement (odd ratio [OR]: 3.27, 95% confidence interval [CI]: 1.33–9.32, P = 0.015) and noninvasive ventilation (OR: 6.17, 95% CI: 2.71–14.07, P < 0.001) were associated with a higher mortality rate while discharging on digoxin (OR: 0.14, 95% CI: 0.02–0.52, P = 0.011) was linked to lower mortality. The sole distinction among HF groups was observed in 12-month survival, with HFpEF patients having a superior survival rate of 91.7% compared to HFIEF patients at 77.5% and HFmrEF at 77.8% during this period. Conclusions: This study found significant differences in all-cause mortality at 12 months. Further research is warranted to better understand the mechanisms underlying these associations.Keywords
This publication has 35 references indexed in Scilit:
- Interaction of Heart Failure and Stroke: A Clinical Consensus Statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on ThrombosisEuropean Journal of Heart Failure, 2023
- Changes in Mortality in Top 10 Causes of Death from 2011 to 2018Journal of General Internal Medicine, 2020
- Stroke and Systemic Embolism and Other Adverse Outcomes of Heart Failure With Preserved and Reduced Ejection Fraction in Patients With Atrial Fibrillation (from the COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF])The American Journal of Cardiology, 2020
- Incidence and Impact of Cardiorenal Anaemia Syndrome on All-Cause Mortality in Acute Heart Failure Patients Stratified by Left Ventricular Ejection Fraction in the Middle EastESC Heart Failure, 2018
- Clinical Characteristics, Management, and Outcomes of Acute Heart Failure Patients: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE)European Journal of Heart Failure, 2015
- Comparison of Outcomes After Hospitalization for Worsening Heart Failure, Myocardial Infarction, and Stroke in Patients with Heart Failure and Reduced and Preserved Ejection FractionEuropean Journal of Heart Failure, 2014
- Heart failure in acute ischemic strokeJournal of Neurology, 2008
- Ischemic stroke after heart failure: A community-based studyAmerican Heart Journal, 2006
- The Irbesartan in Heart Failure With Preserved Systolic Function (I-PRESERVE) Trial: Rationale and DesignJournal of Cardiac Failure, 2005
- Manifestations of Coronary Disease Predisposing to StrokeJAMA, 1983